
Content reviewed · Sources & review policy
Quick answer: A custom blend starts with defined component identities and a testable cosmetic objective. Ratios, excipients and analytical methods must be considered together.
What must be defined before developing a multi-peptide blend?
Explain the intended skincare product, target market, carrier system and appearance goals. State whether the project is a new concept or a revision of an established formula. Include ingredient restrictions and the packaging environment so the development brief reflects real product constraints.
List the exact peptide names and intended content basis. Percentages can refer to a supplied solution, a raw powder or the final product, so label each clearly. The component ratios should be documented rather than inferred from a total blend weight or a marketing name.
Agree whether a ratio describes ingredient input, dry blend mass or measured target-peptide content. These are different bases and can produce different purchase requirements. A blend name such as firming or hydration describes a development objective, not the quantitative composition. Keep a component register with exact identities and version numbers so a changed supplier preparation cannot silently change the product.
How should blend ratios and changes be documented?
Ask how identity and relevant content will be evaluated when several components are present together. Review whether the agreed analytical method can distinguish the ingredients of interest. Physical appearance, dissolution and stability checks should be appropriate to the blend and its intended use.
Keep an approved composition revision linked to the sample and packaging. If a component, carrier or fill format changes, identify which assessments need to be repeated. A clear change record makes a multi-peptide OEM project easier to reproduce and compare across future orders.
Use a worked brief rather than an assumed formula: a proposed 60:40 ratio must state what the two quantities measure, whether carriers are included and how the ratio will be checked. Those numbers are an illustrative request format, not a recommended recipe. A component, carrier or ratio change should be evaluated against the approved sample and recorded before the next commercial batch.
Parameters to record
- Components: exact identities and carrier declarations
- Ratio: specify the denominator and verification method
- Changes: approval owner, revision and affected batches
Frequently asked questions
Is a blend ratio always a peptide-content ratio?
No. The ratio basis must be explicitly defined.
Can a supplier substitute a component without reapproval?
The agreed change-control requirements should govern any substitution.
Related reading

Private-Label Peptide Vials: A Project Checklist
A private-label vial project needs more than a logo and a fill weight. Define composition, peptide content, container, closure, artwork and release documentation.
Read guide →
Bulk Powder, Individual Vials or Cosmetic Kits?
Choose the format around handling, evaluation needs and the finished product plan. Bulk packs and private-label kits solve different sourcing problems.
Read guide →
How to Write a Cosmetic Peptide OEM Project Brief
A concise brief should define the product concept, exact ingredient or blend, content, format, quantity, destination and approval requirements.
Read guide →